(Q43828756)

27 November 2017

title

Kinetic parameters for small-molecule drug delivery by covalent cell surface targeting (English)

1 reference

27 November 2017

1 reference

D A Nauman

1

1 reference

27 November 2017

C R Bertozzi

series ordinal

2

1 reference

27 November 2017

publication date

1 December 2001

1 reference

Biochimica et Biophysica Acta

27 November 2017

published in

1 reference

27 November 2017

volume

1568

1 reference

27 November 2017

issue

2

1 reference

27 November 2017

page(s)

147-154

1 reference

Tumor Heterogeneity and Immunotherapy of Cancer

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4165%2801%2900211-2

7 January 2021

Monoclonal antibodies in drug targeting

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4165%2801%2900211-2

7 January 2021

Novel therapeutic strategies to selectively kill cancer cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4165%2801%2900211-2

7 January 2021

Cytotoxic agents directed to peptide hormone receptors: defining the requirements for a successful drug

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4165%2801%2900211-2

7 January 2021

Multi-drug delivery system using streptavidin-transforming growth factor-alpha chimeric protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4165%2801%2900211-2

7 January 2021

Cure of xenografted human carcinomas by BR96-doxorubicin immunoconjugates

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4165%2801%2900211-2

7 January 2021

Treatment of ovarian cancer with photodynamic therapy and immunoconjugates in a murine ovarian cancer model

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4165%2801%2900211-2

7 January 2021

Phase-I/II radio-immunotherapy study with Iodine-131-labeled anti-CEA monoclonal antibody F6 F(ab')2 in patients with non-resectable liver metastases from colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4165%2801%2900211-2

7 January 2021

Chemoselective approaches to glycoprotein assembly

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4165%2801%2900211-2

7 January 2021

Chemoselective ligation reactions with proteins, oligosaccharides and cells

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4165%2801%2900211-2

7 January 2021

Engineering chemical reactivity on cell surfaces through oligosaccharide biosynthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4165%2801%2900211-2

7 January 2021

Metabolic delivery of ketone groups to sialic acid residues. Application To cell surface glycoform engineering

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4165%2801%2900211-2

7 January 2021

Engineering novel cell surface receptors for virus-mediated gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4165%2801%2900211-2

7 January 2021

Sialylation and malignant potential in tumour cell glycosylation mutants

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4165%2801%2900211-2

7 January 2021

Characterization of rapid membrane internalization and recycling

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4165%2801%2900211-2

7 January 2021

(6-Maleimidocaproyl)hydrazone of doxorubicin--a new derivative for the preparation of immunoconjugates of doxorubicin

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4165%2801%2900211-2

7 January 2021

Reduced temperature prevents transfer of a membrane glycoprotein to the cell surface but does not prevent terminal glycosylation

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4165%2801%2900211-2

7 January 2021

Membrane transport in the endocytic pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4165%2801%2900211-2

7 January 2021

Bafilomycin A1 treatment retards transferrin receptor recycling more than bulk membrane recycling

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4165%2801%2900211-2

7 January 2021

Monoclonal antibody conjugates of doxorubicin prepared with branched linkers: A novel method for increasing the potency of doxorubicin immunoconjugates

1 reference

https://api.crossref.org/works/10.1016%2FS0304-4165%2801%2900211-2

7 January 2021

10.1016/S0304-4165(01)00211-2

Identifiers

DOI

1 reference

27 November 2017

1 reference